Erion Dobi

519 citations

31 papers · 356 indexed · h-index 14

Impact in

Oncology
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
Cancer Research
- Breast Cancer Treatment Studies

Papers in ⓘ

Oncology 25
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 7
- HER2/EGFR in Cancer Research 6
- Lung Cancer Research Studies 3
Cancer Research 9
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 4

Co-authors: Xavier Pivot (21 shared papers)L. Chaigneau (21 shared papers)Fernando Bazán (17 shared papers)Antoine Thiery-Vuillemin (13 shared papers)Stéfano Kim (7 shared papers)Cristian Villanueva (12 shared papers)Martin Demarchi (7 shared papers)Thierry Nguyen (7 shared papers)
Journals: BMC Cancer (3 papers)Journal of Clinical Oncology (3 papers)The Breast (2 papers)Annals of Oncology (2 papers)Scientific Reports (1 paper)
Partner nations: France United States Albania

In The Last Decade

Erion Dobi

31 papers receiving 351 citations

Peers

Countries citing papers authored by Erion Dobi

Since Specialization

Citations

This map shows the geographic impact of Erion Dobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erion Dobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erion Dobi more than expected).

Fields of papers citing papers by Erion Dobi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erion Dobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erion Dobi. The network helps show where Erion Dobi may publish in the future.

Co-authors

The 25 scholars most cited alongside Erion Dobi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erion Dobi Line = papers co-authored together Erion Dobi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Second-line endocrine therapy (ET) with or without palbociclib (P) maintenance in patients (pts) with hormone receptor-positive (HR[+])/human epidermal growth factor receptor 2-negative (HER2[-]) advanced breast cancer (ABC): PALMIRA trial. Journal of Clinical Oncology ·Antonio Llombart‐Cussac, Catherine Harper‐Wynne, Antonia Perelló, Audrey Hennequin, Adela Fernández, Marco Colleoni, Vicente Carañana, Vanesa Quiroga, Jacques Médioni, Vega Iranzo, Duncan Wheatley, Sonia Del Barco, Antonio Antón, Erion Dobi, Manuel Ruíz‐Borrego, Daniel Alcalá-López, Jhudit Pérez‐Escuredo, Miguel Sampayo-Cordero, José Manuel Pérez-García, Javier Cortés	2023	42
2	Cabazitaxel Drugs ·Cristian Villanueva, Fernando Bazán, Stéfano Kim, Martin Demarchi, L. Chaigneau, Antoine Thiery-Vuillemin, Thierry Nguyen, L. Cals, Erion Dobi, Xavier Pivot	2011	41
3	Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer Clinical Colorectal Cancer ·Erion Dobi, Franck Monnien, Stéfano Kim, Arben Ivanaj, Thiery N'Guyen, Martin Demarchi, Olivier Adotévi, Antoine Thiery-Vuillemin, M. Jary, B Kantelip, Xavier Pivot, Yann Godet, Séverine Valmary Degano, Christophe Borg	2012	34
4	Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy The Breast ·Natacha Chaumard, Samuel Limat, Cristian Villanueva, Virginie Nerich, Philippe Fagnoni, Fernando Bazán, L. Chaigneau, Erion Dobi, L. Cals, Xavier Pivot	2011	21
5	In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy? The Oncologist ·Xavier Pivot, Laura Mansi, L. Chaigneau, Philippe Montcuquet, Antoine Thiery-Vuillemin, Fernando Bazán, Erion Dobi, Jean Loup Sautière, Frederic Rigenbach, M.-P. Algros, Steve Butler, Farid Jamshidian, Phillip G. Febbo, Christer Svedman, Sophie Paget‐Bailly, Franck Bonnetain, Christian Villanueva	2015	19
6	Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy BMC Gastroenterology ·Frédéric Fiteni, Marine Jary, Franck Monnien, Thierry Nguyen, Eric Beohou, Martin Demarchi, Erion Dobi, Francine Fein, D Cléau, Serge Fratté, Virginie Nerich, Franck Bonnetain, Xavier Pivot, Christophe Borg, Stéfano Kim	2014	19
7	Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels BMC Cancer ·Stéfano Kim, Erion Dobi, Marine Jary, Franck Monnien, Elsa Curtit, Thierry Nguyen, Zaher Lakkis, Bruno Heyd, Serge Fratté, D Cléau, Najib Lamfichekh, Virginie Nerich, Boris Guiu, Martin Demarchi, Christophe Borg	2013	17
8	Prognostic Value of Angiopoietin-2 for Death Risk Stratification in Patients with Metastatic Colorectal Carcinoma Cancer Epidemiology Biomarkers & Prevention ·Marine Jary, Déwi Vernerey, Thierry Lecomte, Erion Dobi, François Ghiringhelli, Franck Monnien, Yann Godet, Stéfano Kim, Olivier Bouché, Serge Fratté, Anthony Gonçalvès, Julie Léger, Lise Queiroz, Olivier Adotévi, Franck Bonnetain, Christophe Borg	2015	16
9	Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab Frontiers in Cardiovascular Medicine ·Quentin Jacquinot, Nathalie Méneveau, Antoine Falcoz, Malika Bouhaddi, Pauline Roux, Bruno Degano, Marion Chatot, Elsa Curtit, Laura Mansi, Marie‐Justine Paillard, Fernando Bazán, L. Chaigneau, Erion Dobi, Guillaume Meynard, Déwi Vernerey, Xavier Pivot, Fabienne Mougin	2022	16
10	Prognostic value of baseline seric Syndecan‐1 in initially unresectable metastatic colorectal cancer patients: a simple biological score International Journal of Cancer ·Marine Jary, Thierry Lecomte, Olivier Bouché, Stéfano Kim, Erion Dobi, Lise Queiroz, François Ghiringhelli, Hélène Etienne, Julie Léger, Yann Godet, Jérémy Balland, Zaher Lakkis, Olivier Adotévi, Franck Bonnetain, Christophe Borg, Déwi Vernerey	2016	15
11	Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer Clinical Medicine Insights Oncology ·Fabien Calcagno, Thierry Nguyen, Erion Dobi, Cristian Villanueva, Elsa Curtit, Stéfano Kim, Philippe Montcuquet, F. Kleinclauss, Xavier Pivot, Antoine Thiery-Vuillemin	2012	15
12	Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer BMC Cancer ·Fernando Bazán, Erion Dobi, Bernard Royer, Elsa Curtit, Luigi Mansi, Nathalie Menneveau, M Paillard, Guillaume Meynard, C. Villanueva, Xavier Pivot, L. Chaigneau	2019	14
13	Is extracapsular tumour spread a prognostic factor in patients with early breast cancer? International Journal of Clinical Oncology ·Erion Dobi, Fernando Bazán, Armelle Dufresne, Martin Demarchi, Cristian Villanueva, L. Chaigneau, Philipe Montcuquet, Arben Ivanaj, Jean Loup Sautière, Y. Maisonnette-Escot, L. Cals, M.-P. Algros, Anne‐Sophie Woronoff, Xavier Pivot	2012	14
14	Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study Molecular and Clinical Oncology ·Matthieu Caubet, Erion Dobi, Astrid Pozet, Hamadi Almotlak, Philippe Montcuquet, Tristan Maurina, Guillaume Mouillet, Thierry Nguyen, Ulrich Stein, Antoine Thiery-Vuillemin, Frédéric Fiteni	2015	13
15	Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer—Study BES 06 Targeted Oncology ·Christian Villanueva, Gilles Romieu, J Salvat, L. Chaigneau, Yacine Merrouche, Trang Huyen Thi Nguyen, Antoine Thiery-Vuillemin, Martin Demarchi, Erion Dobi, Xavier Pivot	2013	9
16	Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: Impact of institutions The Breast ·Frédéric Fiteni, Cristian Villanueva, Fernando Bazán, Sophie Perrin, L. Chaigneau, Erion Dobi, Philippe Montcuquet, L. Cals, Nathalie Méneveau, Virginie Nerich, Samuel Limat, Xavier Pivot	2013	9
17	Évaluation économique de l’utilisation en routine du test Oncotype DX® dans la prise en charge des cancers du sein en Franche-Comté Bulletin du Cancer ·Virginie Nerich, Elsa Curtit, Fernando Bazán, Philippe Montcuquet, Cristian Villanueva, L. Chaigneau, L. Cals, Nathalie Méneveau, Erion Dobi, Hamadi Altmotlak, Marie‐Paule Algros, Marie-Jeanne Choulot, Gilles Nallet, Samuel Limat, Sylvie Mansion, Xavier Pivot	2014	6
18	Specific anticancer treatments in the last 3 months of life: a French experience Supportive Care in Cancer ·É. Viel, L. Chaigneau, Eleonor Fanton, Elsa Kalbacher, Antoine Thiery-Vuillemin, Cristian Villanueva, Erion Dobi, Elsa Curtit, Hamadi Almotlak, Régis Aubry, Xavier Pivot	2012	5
19	Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry Scientific Reports ·Zohair Selmani, Chloé Molimard, Alexis Overs, Fernando Bazán, L. Chaigneau, Erion Dobi, Nathalie Méneveau, Laura Mansi, Marie‐Justine Paillard, Guillaume Meynard, Julien Viot, Marie‐Paule Algros, Christophe Borg, Jean‐Paul Feugeas, Xavier Pivot, Jean‐Luc Prétet, Elsa Curtit	2022	4
20	Feasibility of treatment with another CDK4/6 inhibitor after severe ribociclib liver toxicity. Journal of Clinical Oncology ·Jean-Philippe Zurcher, Morgan Goujon, Paul Cottu, Isabelle Desmoulins, Luís Teixeira, Laura Mansi, Guillaume Meynard, Erion Dobi, Elise Rowinski, Marion Stacoffe, Paule Augereau, Marie Robert, Y Mottaz, Anaïs Gaiffe, Aurélie Grandvuillemin, Mapi Fleury, Ana Dolcan, Athina Stravodimou, Khalil Zaman, Elsa Curtit	2023	4

About Erion Dobi

Erion Dobi is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Gastroenterology, having authored 31 papers that have together received 356 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (7 papers), HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Research Studies (3 papers), Prostate Cancer Treatment and Research (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Oncology (217 citations), Cancer Research (111 citations), Pulmonary and Respiratory Medicine (147 citations), Genetics (23 citations) and Hepatology (16 citations). Erion Dobi has collaborated with scholars based in France, United States and Albania. Frequent co-authors include Xavier Pivot, L. Chaigneau, Fernando Bazán, Antoine Thiery-Vuillemin, Stéfano Kim, Cristian Villanueva, Martin Demarchi, Thierry Nguyen, L. Cals and Christophe Borg. Their work appears in journals such as BMC Cancer, Journal of Clinical Oncology, The Breast, Annals of Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact